Tafamidis: is it truly a game changer for transthyretin amyloid cardiomyopathy?
Indian Pacing and Electrophysiology Journal · 2026-09 · 26 (5) · 533-538
DOI: 10.1016/j.ipej.2026.10.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Pacing and Electrophysiology Journal, 2026-09. Verfasst von Sarena Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Touro University Nevada College of Osteopathic Medicine, United States. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Touro University Nevada College of Osteopathic Medicine, United States.
- California University of Science and Medicine, United States.
- Division of Cardiology, Department of Medicine, University of California San Francisco, United States; Advanced Heart Failure Comprehensive Care Center, UCSF Health, United States. Electronic address: mandar.aras@ucsf.e…
Förderung
- Pfizer
Zitieren
APA
Yang, S., Hyun, J., & Aras, M. A. (2026). Tafamidis: is it truly a game changer for transthyretin amyloid cardiomyopathy?. Indian Pacing and Electrophysiology Journal, 26(5), 533-538. https://doi.org/10.1016/j.ipej.2026.10.002
Vancouver
Yang S, Hyun J, Aras MA. Tafamidis: is it truly a game changer for transthyretin amyloid cardiomyopathy?. Indian Pacing and Electrophysiology Journal. 2026;26(5):533-538. doi:10.1016/j.ipej.2026.10.002
BibTeX
@article{Yang2026,
author = {Yang, Sarena and Hyun, Justin and Aras, Mandar A},
title = {Tafamidis: is it truly a game changer for transthyretin amyloid cardiomyopathy?},
journal = {Indian Pacing and Electrophysiology Journal},
year = {2026},
volume = {26},
number = {5},
pages = {533--538},
doi = {10.1016/j.ipej.2026.10.002}
}
EUVIMED